Disclosure of total number of voting rights and number of shares in the capital as of July 31st, 2023

Sophia Antipolis, France

Press release – For immediate release – 5:45 pm  CEST

Disclosure of total number of voting rights and number of shares in the capital as of July 31st, 2023, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.

Total number of shares18,270,608
Number of real voting rights* (excluding treasury shares**)18,211,483
Theoretical number of voting rights* (including treasury shares**)18,247,408
(*) Class E preference shares are non-voting
(**) pursuant to article 223-11 of the AMF’s General Regulations
Download 20230804_PR_shares_votingrights_July2023.pdf

About Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonis™, our AI/ML tech-based suite of software as medical devices (SaMD), help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com

 

Contacts

Median Technologies
Emmanuelle Leygues
Head of Corporate Marketing and Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Press – ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com

Investors – ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
ggasparetto@actifin.fr